# Pliant Therapeutics, Inc.: Form 8-K, filed May 1, 2025

- Company: [Pliant Therapeutics, Inc.](/companies/plrx.md) (CIK 1746473)
- Form: 8-K
- Filed: 2025-05-01
- Accepted by EDGAR: May 1, 2025, 20:13 ET
- Period: 2025-05-01
- Accession: 0001193125-25-109976
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1746473/000119312525109976/d949809d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1746473/000119312525109976/

## Items reported

- Item 2.05: Exit or disposal costs
- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1746473/000119312525109976/d949809d8k.htm

Filed May 1, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-109976. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.